Mini Nicotine Lozenge
Product Images NDC 79481-0301

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mini Nicotine (NDC 79481-0301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mini Nicotine Lozenge Carton (6u4c16ec1)

This is a medication information sheet for Meijer Mini Nicotine Lozenges, designed as a stop-smoking aid with a lime flavor. Each lozenge contains 4mg of nicotine polacrilex. The directions include information on how to use the lozenges correctly and warnings about possible side effects and risks associated with nicotine use. It is essential to consult a doctor before using this product, especially for individuals under 18 years old, pregnant, or breastfeeding women, or those with certain medical conditions like heart disease or diabetes. The contact information for further questions or comments is provided at the end of the sheet.*

FDA Label Image

Wallet Card Image 1 (Image 01)

FDA Label Image

Wallet Card Image 2 (Image 02)

This text provides a list of emergency contacts that can be carried in a wallet card for quick reference in case of need help. It includes contact numbers for the American Lung Association, American Cancer Society, and American Heart Association, as well as guidance to reach out to a Quitting Buddy or a Friend who has Quit for support. This information can be invaluable in urgent situations requiring assistance.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

Free & Personalized Support Plan with IS_I okeFree Habits.com.*

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

This text provides reminders for a step-by-step plan to quit smoking by using lozenges at specified intervals during the first 12 weeks. It suggests specific dosages every 1-2 hours in the initial week, followed by adjustments in the following weeks. It advises ex-smokers to mark important dates on their calendars such as the quit date and week #7, as well as to continue monitoring progress up to week #12 post-quit date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.